Literature DB >> 33603079

Association between EBV serological patterns and lymphocytic profile of SjS patients support a virally triggered autoimmune epithelitis.

Filipe Barcelos1,2,3,4, Catarina Martins5,6, Ricardo Monteiro5,6, Joana Cardigos7, Tiziano Prussiani6, Miguel Sítima6, Nuno Alves7,8, José Vaz-Patto9, Jaime Cunha-Branco5,6,10,11, Luís-Miguel Borrego5,6,12.   

Abstract

Sjögren's syndrome (SjS) is characterized by lymphocytic infiltration of exocrine glands, i.e. autoimmune epithelitis. Lymphocytes are central in SjS pathogenesis, with B-cell hyperactivity mediated by T-cells. B-cells are main targets of Epstein-Barr virus (EBV) infection, a frequently-suggested trigger for SjS. We aimed to evaluate how the EBV infection modulates B and T-cell subsets in SjS, including as controls Rheumatoid arthritis patients (RA) and healthy participants (HC). SjS patients presented decreased CXCR5+T-cells, although IL21-secreting Tfh and Tfc cells were increased. Tfc were positively correlated with ESSDAI scores, suggesting their relevant role in SjS pathogenesis. As previously described, SjS patients showed expanded circulating naïve B-cell compartments. SjS patients had a higher incidence of EBV-EA-D-IgG+ antibodies, characteristic of recent EBV-infection/reactivation. SjS patients with past infection or recent infection/reactivation showed increased CXCR3+Th1 and CXCR3+Tfh1 cells compared to those without active infection. SjS patients with a recent infection/reactivation profile presented increased transitional B-cells compared to patients with past infection and increased plasmablasts, compared to those without infection. Our results suggest EBV-infection contributes to B and T-cell differentiation towards the effector phenotypes typical of SjS. Local lymphocyte activation at ectopic germinal centres, mediated by Tfh and Tfc, can be EBV-driven, perpetuating autoimmune epithelitis, which leads to gland destruction in SjS.

Entities:  

Mesh:

Year:  2021        PMID: 33603079      PMCID: PMC7893064          DOI: 10.1038/s41598-021-83550-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  47 in total

1.  Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.

Authors:  Ya-Zhuo Gong; Joanne Nititham; Kim Taylor; Corinne Miceli-Richard; Christelle Sordet; Dominique Wachsmann; Siamak Bahram; Philippe Georgel; Lindsey A Criswell; Jean Sibilia; Xavier Mariette; Ghada Alsaleh; Jacques-Eric Gottenberg
Journal:  J Autoimmun       Date:  2014-01-09       Impact factor: 7.094

2.  A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.

Authors:  Esha Abrol; Cristina González-Pulido; Juan M Praena-Fernández; David A Isenberg
Journal:  Clin Med (Lond)       Date:  2014-04       Impact factor: 2.659

3.  Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome.

Authors:  Arne Hansen; Marcus Odendahl; Karin Reiter; Annett M Jacobi; Eugen Feist; Jürgen Scholze; Gerd R Burmester; Peter E Lipsky; Thomas Dörner
Journal:  Arthritis Rheum       Date:  2002-08

4.  IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism.

Authors:  Dimitra Zotos; Jonathan M Coquet; Yang Zhang; Amanda Light; Kathy D'Costa; Axel Kallies; Lynn M Corcoran; Dale I Godfrey; Kai-Michael Toellner; Mark J Smyth; Stephen L Nutt; David M Tarlinton
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

Review 5.  B cells in the pathogenesis of primary Sjögren syndrome.

Authors:  Gaëtane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2018-02-08       Impact factor: 20.543

6.  Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome.

Authors:  Krisztina Szabo; Gabor Papp; Sandor Barath; Edit Gyimesi; Antonia Szanto; Margit Zeher
Journal:  Clin Immunol       Date:  2013-03-15       Impact factor: 3.969

7.  Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay.

Authors:  Irene Cassaniti; Lorenzo Cavagna; Sandra A Calarota; Kodjo Messan Guy Adzasehoun; Giuditta Comolli; Carlomaurizio Montecucco; Fausto Baldanti
Journal:  J Immunol Res       Date:  2019-02-17       Impact factor: 4.818

8.  Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sjögren's syndrome.

Authors:  Cristina Croia; Elisa Astorri; William Murray-Brown; Amanda Willis; Karl A Brokstad; Nurhan Sutcliffe; Kim Piper; Roland Jonsson; Anwar R Tappuni; Costantino Pitzalis; Michele Bombardieri
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

9.  A Subset of CXCR5+CD8+ T Cells in the Germinal Centers From Human Tonsils and Lymph Nodes Help B Cells Produce Immunoglobulins.

Authors:  Juan Shen; Xi Luo; Qiongli Wu; Jun Huang; Guanying Xiao; Liantang Wang; Binyan Yang; Huabin Li; Changyou Wu
Journal:  Front Immunol       Date:  2018-10-05       Impact factor: 7.561

Review 10.  The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog.

Authors:  Heather M Long; Benjamin J Meckiff; Graham S Taylor
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

View more
  1 in total

1.  Hospitalizations for infections in primary Sjögren's syndrome patients: a nationwide incidence study.

Authors:  Radjiv Goulabchand; Alain Makinson; Jacques Morel; Philine Witkowski-Durand-Viel; Nicolas Nagot; Paul Loubet; Camille Roubille; Danièle Noel; David Morquin; Kim Henry; Thibault Mura; Philippe Guilpain
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.